Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican, Ahmet; Kucukzeybek, Betul; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Erten, Cigdem; Varol, Umut; Somali, Isil; Demir, LÜTFİYE; Bayoglu, Ibrahim; Yildiz, Yasar; Akyol, Murat; Koyuncu, Betul; Coban, Eyup; Ulger, Eda; Unay, Fulya; Tarhan, Mustafa

doi:10.1007/s10147-014-0672-8

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Copy For Citation

Dirican A., Kucukzeybek B. B., Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., ...More

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.20, pp.70-81, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 20
Publication Date: 2015
Doi Number: 10.1007/s10147-014-0672-8
Journal Name: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.70-81
Eskisehir Osmangazi University Affiliated: No

Abstract

Background The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with cancer. Similarly, a study in a large series has shown that the newly defined derived NLR (dNLR; neutrophil/leukocyte-lymphocyte ratio) also has prognostic value. The present study retrospectively evaluates the prognostic significance of NLR and dNLR in breast cancer.